Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiretroviral Agents”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00059384
What this trial is testing

Alternative Dosing Strategy for Anti-HIV Drugs

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 66
Post-approval studies (Phase 4)Study completedNCT02519777
What this trial is testing

Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 191
Not applicableStudy completedNCT02004314
What this trial is testing

Chloroquine as a Modulator of T Cell Immune Activation

Who this might be right for
HIV
CIHR Canadian HIV Trials Network 19
Large-scale testing (Phase 3)Study completedNCT01709084
What this trial is testing

A Clinical Trial Comparing the Efficacy of Tenofovir Disoproxil Fumarate/Emtricitabine/Rilpivirine (TDF/FTC/RPV) Versus TDF/FTC/Efavirenz (TDF/FTC/EFV) in Patients With Undetectable Plasma HIV-1 RNA on Current First-line Treatment

Who this might be right for
Human Immunodeficiency Virus-type 1 Infection
Janssen-Cilag International NV 426
Not applicableStudy completedNCT01637233
What this trial is testing

MARCH Central Nervous System Substudy

Who this might be right for
HIV-1 Infection
Kirby Institute 28
Large-scale testing (Phase 3)WithdrawnNCT01255371
What this trial is testing

A Multicentre Trial of Second-line Antiretroviral Treatment Strategies in African Adults Using Atazanavir or Lopinavir/Ritonavir

Who this might be right for
HIV
ANRS, Emerging Infectious Diseases
Not applicableStudy completedNCT02167100
What this trial is testing

Patient Retention in HIV Medical Care in a Primary Care Practice in Australia

Who this might be right for
HIV
Holdsworth House Medical Practice 1,537
Not applicableStudy completedNCT04133012
What this trial is testing

Cartography of Virologic Reservoir Related to Antiretroviral Concentrations in HIV-1 Chronic Patients Treated by a First Line Treatment Containing Dolutegravir and Associated Nucleoside / Nucleotide Reverse Transcriptase Inhibitors Backbone

Who this might be right for
HIV-1 Infection
ANRS, Emerging Infectious Diseases 20
Not applicableUnknownNCT02097381
What this trial is testing

Study of Recovery of Intestinal CD4+ and Th17 T Cells in HIV-infected Individuals on Short-term Antiretroviral Therapy

Who this might be right for
HIV Infection
University of Roma La Sapienza 10
Large-scale testing (Phase 3)Study completedNCT01924286
What this trial is testing

Preventing TB-IRIS in High-risk Patients: a Randomized Placebo-controlled Trial of Prednisone

Who this might be right for
Immune Reconstitution Inflammatory SyndromeHIVTuberculosis
University of Cape Town 240
Testing effectiveness (Phase 2)Study completedNCT00002357
What this trial is testing

The Safety and Effectiveness of HBY 097 Used With or Without AZT in HIV-Infected Patients Who Have Mild or No Symptoms

Who this might be right for
HIV Infections
Hoechst Marion Roussel 144
Not applicableStudy completedNCT03825523
What this trial is testing

Immediate ART in Subjects With Opportunistic Diseases

Who this might be right for
HIV/AIDSANTIRETROVIRAL TREATMENT
Gustavo Reyes-Teran 114
Post-approval studies (Phase 4)Study completedNCT04388904
What this trial is testing

Rapid Reinitiation of a Single Tablet Antiretroviral Therapy Using Symtuza® in HIV-1 Infected Treatment-Experienced Patients Off Therapy. (ReSTART)

Who this might be right for
HIV-1-infection
The Crofoot Research Center, Inc. 75
Not applicableLooking for participantsNCT06659315
What this trial is testing

Prevention of Mother-to-child Transmission (PMTCT) Among Women Experiencing Depression in Malawi

Who this might be right for
HIV Antiretroviral Therapy (ART) AdherencePerinatal Mental HealthDepression During Pregnancy+1 more
University of California, San Francisco 180
Not applicableUnknownNCT02337504
What this trial is testing

Developing and Assessing a Community Based Model of Antiretroviral Care

Who this might be right for
HIV
Moi University 360
Post-approval studies (Phase 4)UnknownNCT01453933
What this trial is testing

RAltegravir Switch STudy: Effects on Endothelial Recovery

Who this might be right for
HIV InfectionEndothelial Dysfunction
UMC Utrecht 24
Not applicableStudy completedNCT00602758
What this trial is testing

Effectiveness of Enhanced Counseling and Observed Therapy on Antiretroviral Adherence in People With HIV

Who this might be right for
HIV InfectionsAcquired Immunodeficiency Syndrome
University of Missouri, Kansas City 252
Early research (Phase 1)Looking for participantsNCT03729752
What this trial is testing

PET Imaging of Radiolabeled Anti-HIV-1 Envelope Monoclonal Antibody (VRC01)

Who this might be right for
HIV-1-infection
University of California, San Francisco 30
Large-scale testing (Phase 3)Active Not RecruitingNCT05631093
What this trial is testing

A Switch to Doravirine/Islatravir (DOR/ISL) in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Who Are Virologically Suppressed on Antiretroviral Therapy (ART) (MK-8591A-051)

Who this might be right for
HIV-1 Infection
Merck Sharp & Dohme LLC 553
Not applicableUnknownNCT00525239
What this trial is testing

HIV Antiretroviral Drugs and Metabolism

Who this might be right for
HIV Infections
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 60
Next Page